课题基金 / 基金详情

A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE

A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE
科帕松加雌三醇治疗多发性复发缓解的联合试验
批准号：
8171164
负责人：
RHONDA R VOSKUHL
金额：
$0.61万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-08-01 至 2011-07-31
来源：
https://reporter.nih.gov/project-details/8171164
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseCopaxoneDiseaseEstriolFundingGrantImageInstitutionMeasuresOralRelapseRelapsing-Remitting Multiple SclerosisResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthWomandouble-blind placebo controlled trial

项目摘要

项目成果

RHONDA R VOSKUHL的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 “克帕松加雌三醇治疗复发缓解型多发性硬化症的联合试验” 一项多中心双盲安慰剂对照试验，以确定口服雌三醇治疗是否能有效降低复发缓解型多发性硬化症女性患者的疾病活动性，通过复发率，成像和免疫学标志物进行测量。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. "A combination trial of copaxone plus estriol in relapsing remitting multiple sclerosis" A multicenter double blind placebo controlled trial to determine if oral estriol treatment is effective in decreasing disease activity in women with relapsing remitting multiple sclerosis as measured by relapse rate, imaging and immunological markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
海外基金